Cargando…

Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension

Lactoferrin (LF), a multifunctional glycoprotein found in mammalian milk, is reported to have immunoregulatory effects. The present study aimed to evaluate whether enteric-coated LF (eLF) could improve symptoms in patients with atopic keratoconjunctivitis (AKC). This randomized double-blind placebo-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujishima, Hiroshi, Okada, Naoko, Matsumoto, Kenji, Shimizu, Eisuke, Fukuda, Shinji, Tomita, Masaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599790/ https://www.ncbi.nlm.nih.gov/pubmed/32992801 http://dx.doi.org/10.3390/jcm9103093

Ejemplares similares

Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis
por: Wakamatsu, Tais Hitomi, et al.
Publicado: (2011)

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases
por: Yazu, Hiroyuki, et al.
Publicado: (2021)

Evaluation of conjunctival inflammatory status by confocal scanning laser microscopy and conjunctival brush cytology in patients with atopic keratoconjunctivitis (AKC)
por: Wakamatsu, Tais Hitomi, et al.
Publicado: (2009)

Analysis of the Conjunctival Microbiome in Patients with Atopic Keratoconjunctivitis and Healthy Individuals
por: Hur, Min Seok, et al.
Publicado: (2021)

Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
por: Al-Amri, Abdulrahman Mohammed, et al.
Publicado: (2017)

Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis
por: Saha, Bhawesh Chandra, et al.
Publicado: (2023)

The importance of tacrolimus in the treatment of allergic keratoconjunctivitis
por: Araujo, Georgia, et al.
Publicado: (2015)

Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis
por: Al-Amri, Abdulrahman M., et al.
Publicado: (2016)

Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus
por: Hirota, Akira, et al.
Publicado: (2022)

Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study
por: Chen, Minjie, et al.
Publicado: (2021)

Conjunctival Inclusion Cysts in Long-standing Chronic Vernal Keratoconjunctivitis
por: Lee, Seung-Won, et al.
Publicado: (2007)

Desiccation Induced Conjunctival Monocyte Recruitment and Activation - Implications for Keratoconjunctivitis
por: Alam, Jehan, et al.
Publicado: (2021)

An observational study on the presence of perilimbal conjunctival pigmentation in vernal keratoconjunctivitis
por: Dubbaka, Srujana, et al.
Publicado: (2023)

Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis
por: Shoughy, Samir S, et al.
Publicado: (2016)

To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital
por: Sruthi, Vadlakonda, et al.
Publicado: (2020)

Central Corneal Thickness in Patients with Atopic Keratoconjunctivitis
por: Ondas, Osman, et al.
Publicado: (2014)

Effect of storage temperature on the dispersibility of commercially available 0.1% fluorometholone ophthalmic suspension
por: Obata, Tokio, et al.
Publicado: (2022)

Elevated levels of prostaglandin E(2) in the tears of patients with severe allergic conjunctivitis and primary cultured conjunctival cells are suppressed by ketotifen and dexamethasone
por: Yamanishi, Ryutaro, et al.
Publicado: (2021)

Conjunctival Autograft for Bilateral Tarsal Keratinization in a Case of Chronic Vernal Keratoconjunctivitis
por: Kate, Anahita, et al.
Publicado: (2022)

Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach
por: Ghiglioni, Daniele Giovanni, et al.
Publicado: (2020)

Keratoconjunctivitis caused by an unusual retained conjunctival foreign body: A frequently unrecognized entity
por: Kalavathy, Catti Muniswamy, et al.
Publicado: (2014)

Atopic keratoconjunctivitis complicated by Kocuria koreensis keratitis: the first case
por: Inada, Noriko, et al.
Publicado: (2017)

Atopic keratoconjunctivitis: A diagnostic dilemma—a case report
por: Li, Aipeng, et al.
Publicado: (2018)

Association Between Atopic Keratoconjunctivitis and the Risk of Recurrent Corneal Erosion
por: Jan, Ren-Long, et al.
Publicado: (2021)

Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials
por: Zhao, Min, et al.
Publicado: (2022)

Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis
por: Albarry, Maan Abdullah, et al.
Publicado: (2022)

Severity of Sjögren’s Syndrome Keratoconjunctivitis Sicca Increases with Increased Percentage of Conjunctival Antigen-Presenting Cells
por: Pflugfelder, Stephen C., et al.
Publicado: (2018)

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
por: Orii, Yusuke, et al.
Publicado: (2023)

Tacrolimus ointment in the management of atopic dermatitis
por: Baldo, Antonello, et al.
Publicado: (2009)

Topical tacrolimus as treatment of atopic dermatitis
por: Furue, Masutaka, et al.
Publicado: (2009)

Management of Atopic Dermatitis: The Role of Tacrolimus
por: Umar, Badar Uddin, et al.
Publicado: (2022)

Ophthalmic manifestations of atopic dermatitis
por: Pietruszyńska, Marta, et al.
Publicado: (2018)

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
por: Gaynes, Bruce I, et al.
Publicado: (2008)

Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases
por: Barrieu, Marion, et al.
Publicado: (2022)

Clinical Efficacy of Topical Tacrolimus on Conjunctival Hyperemia Caused by Prostaglandin Analogues
por: Yang, Jing, et al.
Publicado: (2022)

Limbitis Secondary to Autologous Serum Eye Drops in a Patient with Atopic Keratoconjunctivitis
por: Welder, Jeffrey David, et al.
Publicado: (2011)

Difference in the plasma level of miR‐628‐3p in atopic dermatitis patients with/without atopic keratoconjunctivitis
por: Ueta, Mayumi, et al.
Publicado: (2021)

Clinical Usefulness of Monitoring Expression Levels of CCL24 (Eotaxin-2) mRNA on the Ocular Surface in Patients with Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
por: Shiraki, Yukiko, et al.
Publicado: (2016)

Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
por: Ryu, Eun Hye, et al.
Publicado: (2012)

Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East
por: Fiorentini, Sandra Flavia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9ca0jbgbfogckj2l91f7h8ssco